Close

Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts Jan 10, 2022 07:30AM
Soligenix Provides Important Highlights and Upcoming Catalysts in Corporate Update Letter Feb 24, 2021 07:00AM
Soligenix Announces Recent Accomplishments And Third Quarter 2020 Financial Results Nov 12, 2020 07:00AM
Soligenix Announces Recent Accomplishments And Second Quarter 2020 Financial Results Aug 14, 2020 07:00AM
Soligenix Issues Corporate Update - Highlights Important Catalysts for Second Half of 2020 Jul 20, 2020 07:00AM


Jun 24, 2020 07:05AM Soligenix, Inc. (SNGX) Reports Complete Enrollment in Pivotal Phase 3 Clinical Trial of SGX942 for Treatment of Oral Mucositis
Jun 24, 2020 07:00AM Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
May 15, 2020 07:00AM Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Jan 14, 2020 07:06AM Soligenix, Inc. (SNGX) provides corporate update and guidance
Jan 14, 2020 07:00AM Soligenix - Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials